Indeed, the AKI prediction marker [TIMP-2]*[IGFBP7] is marketed as point-of-care test and its concentration-based output rapidly increases in response to injury and peaks within 12 h after the insult [39]. The gene discussed is TIMP2; the disease is acute kidney injury.